VLP Therapeutics
Business Services · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
704 Quince Orchard Rd Ste 110, Gaithersb...Phone Number
(240) 801-4456Website
www.vlptherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About VLP Therapeutics
VLP Therapeutics is a MD-based biotech company with a mission to address unmet medical needs worldwide and expand the frontiers of vaccine treatment. This company is currently engaged in research and development of a cancer treatment vaccine as well as prophylactic vaccines against malaria, dengue, and novel coronavirus disease (COVID-19) using VLPT's proprietary platform technologies. Established in 2012, VLP Therapeutics is headquartered in Gaithersburg, Maryland, United States.Explore more
VLP Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VLP Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when VLP Therapeutics launches new products
Check if VLP Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if VLP Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once VLP Therapeutics has new funding data
Click to see if VLP Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at VLP Therapeutics
Earning: See what the market has to say on VLP Therapeutics recently announced quarterly report
VLP Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at VLP Therapeutics
Find more new buyers
Compare Similar Companies to VLP Therapeutics
Compare insights from companies similar to VLP Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
VLP Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
VLP Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about VLP Therapeutics.
VLP Therapeutics financials insights
Gather financial insights about VLP Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Grant
$960K
2021
Series A
$37M
VLP Therapeutics Tech Stack
A closer look at the technologies used by VLP Therapeutics
VLP Therapeutics News & Media
VLP Therapeutics raises $16M Series A for cancer treatment vaccine R&D
GAITHERSBURG, Md., March 15, 2021 /PRNewswire/ -- US-based biotech company VLP Therapeutics, Inc. (VLPT) announced on March 15 that it has raised US$16 million in a Series A funding round from MIYAKO Capital Co., Ltd., Sojitz Corporation, Konishiyasu Co., Ltd., in Japan and three existing...VLP Therapeutics to Initiate First Clinical Trial of VLPM01 Malaria Vaccine
GAITHERSBURG, Md., Feb. 4, 2019 /PRNewswire/ -- VLP Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a clinical trial of the Company's VLPM01 malaria vaccine. The Phase I/IIa clinical trial will...VLP Therapeutics Awarded $3.9 million Grant by Global Health Innovative Technology Fund for Further Development of Dengue Vaccine
GAITHERSBURG, Md., Dec. 12, 2018 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund has awarded VLP Therapeutics a $3.9 million grant to further develop a novel tetravalent dengue virus-like particle vaccine. "The GHIT Fund's commitment is an important step for the...VLP Therapeutics Announces Phase 1 SBIR Grant Award from National Cancer Institute
GAITHERSBURG, Md., Oct. 11, 2017 /PRNewswire/ -- VLP Therapeutics, LLC ("VLP"), a biotechnology company focusing on the research and development of therapeutic and preventative vaccines announced today the receipt of a Phase I grant from the National Cancer Institute under auspices of the...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding VLP Therapeutics
Sign Up For FreeTo access detailed company insights
VLP Therapeutics is a MD-based biotech company with a mission to address unmet medical needs worldwide and expand the frontiers of vaccine treatment. This company is currently engaged in research and development of a cancer treatment vaccine as well as prophylactic vaccines against malaria, dengue, and novel coronavirus disease (COVID-19) using VLP... Read More
